Page 3 - Carnot
P. 3
A unique multidisciplinarity for advanced research
Our added value to prevent and reduce toxicity induced by
immunotherapies
European leader in translational and clinical
research CEPHEPI, our Pharmacoepidemiology Centre
Renowned research teams accross all medical The Pharmaceutical R&D Department (General
specialities Agency for Health Products & equipment)
A fully interconnected ecosystem (N°1 data The AP-HP Health Data Warehouse (Data on
warehouse in Europe, patient cohorts, biological more than 14 million patients)
resource collections, research platforms, etc.) Digital Medical Hub (DMH) specialised in the
A commitment to performance Evaluation of connected medical objects
A new Carnot institute, strenghtening the networks An evaluation platform for innovative biomarkers
integration in medical research SeqOIA, our genomics platform
MOABI, our bioinformatics analysis platform for
diagnostics
Our translational and clinical ComPare, our e-cohorts platform
research platforms PRIM3D, our 3D printing platform
17 Clinical Investigation Centers (CIC) Lumière, our antenatal diagnosis platform
4 Clinical Research Centers (CRC) CRNH, our Human Nutrition Research Centre
384 Rare Disease Reference Centers (CRMR) A reference center for clinical investigation in
3 Integrated cancer research sites (SIRIC) labeled vaccinology
by INCa (the State health and science agency
specialised in cancer control): CURAMUS,
CARPEM, InsiTu
12 Biological Resource Centers coordinated
with a centralised AP-HP Biobank, including the
intestinal microbiota KEY FIGURES
MEARY cGMP production centre dedicated to
Advanced therapy medicinal products 3 370
ATMP qualified internal pharmacies Researchers
Immunology services, with state-of-the-
art immunomonitoring of patients receiving 1 290
immunotherapies Doctoral students
44 M€
Revenue generated
from industrial research
partnerships
